Drug
Hydralazine Hydrochloride And Isosorbide Dinitrate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | End Stage Renal Disease | 29 | 77.3 | 82.8 | signal |
| 2 | Economic Problem | 16 | 50.9 | 52.8 | signal |
| 3 | Cardiomyopathy | 13 | 43.1 | 44.4 | signal |
| 4 | Mitral Valve Incompetence | 8 | 34.7 | 35.3 | signal |
| 5 | Chronic Kidney Disease | 51 | 32.6 | 36.9 | signal |
| 6 | Cardiomegaly | 8 | 31.6 | 32.2 | signal |
| 7 | Ejection Fraction Decreased | 10 | 31.5 | 32.2 | signal |
| 8 | Cardiac Failure Congestive | 42 | 25.4 | 28.0 | signal |
| 9 | Myocardial Ischaemia | 5 | 21.4 | 21.6 | signal |